RxDoctor Payments DataLook up a doctor →

Nicole Grilli, PA

Physician Assistant · Hartford, CTNPI 1710908694

Payments from drug & device makers

$8,958in general payments, 2019–2025

Across 515 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • AstraZeneca$717
  • GSK$472
  • Lilly USA, LLC$345
  • Johnson & Johnson$282
  • plus $4K from 53 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie117$1,574
Novo Nordisk75$1,099
AstraZeneca37$717
GSK25$472
Lilly USA, LLC16$345
Johnson & Johnson14$282
Otsuka America Pharmaceutical, Inc.13$275
Astellas Pharma US Inc12$274
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)14$273
Dexcom, Inc.11$229
Phathom Pharmaceuticals, Inc.22$228
Vanda Pharmaceuticals Inc.10$209
Exact Sciences10$208
Pfizer12$207
Corcept Therapeutics4$196
Amgen11$172
Boehringer Ingelheim8$166
Lundbeck LLC8$140
Novartis6$135
E.r. Squibb & Sons, L.L.C.7$133
Merck6$108
Idorsia Pharmaceuticals US Inc6$100
Abbott6$99
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC5$98
Takeda Pharmaceuticals U.S.A., Inc.4$88
Sanofi-aventis U.S. LLC4$82
Sunovion Pharmaceuticals Inc.5$82
Amneal Pharmaceuticals LLC4$75
Bayer3$69
Resmed Corp1$66
Shield Therapeutics Inc3$58
Eisai Inc.3$53
Sumitomo Pharma America, Inc.3$52
Kowa Pharmaceuticals America, Inc.3$45
Cequr Corporation1$42
Valinor Pharma, LLC2$39
Ardelyx, Inc.2$39
Insightec,inc1$35
Embecta Corp.1$35
Soleno Therapeutics, Inc.1$28
Scilex Pharmaceuticals Inc.1$24
Seqirus USA Inc1$23
Corium, LLC1$23
Almatica Pharma LLC1$22
Teva Pharmaceuticals USA, Inc.1$20
Xeris Pharmaceuticals, Inc.1$20
Antares Pharma, Inc.1$19
Otsuka Pharmaceutical Development & Commercialization, Inc.1$19
Biohaven Pharmaceuticals, Inc.1$17
Axsome Therapeutics, Inc.1$16
Inspire Medical Systems, Inc.1$16
Paratek Pharmaceuticals, Inc.1$16
Amarin Pharma, Inc.1$16
Currax Pharmaceuticals LLC1$15
Avanir Pharmaceuticals, Inc.1$14
Nabriva Therapeutics, PLC1$14
Watermark Medical, Inc.1$14
Collegium Pharmaceutical, Inc.1$14
Mylan Specialty L.p.1$13

How this compares

$8,958 in reported general payments places this provider in the 95th percentile of 1,795 physician assistant providers in Connecticut.

See all physician assistant providers in Connecticut

Medicare billing

Part B allowed, 2024
$19,243
Medicare patients
66
Services billed
313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →